Avery Therapeutics Inc.

United States

2016 2016 Winner | Venture Science Start-ups (Falling Walls Venture)

Presented by
Jen Koevary

Nominated by

The University of Arizona


MyCardia™ has the potential to improve heart function and quality of life in patients with heart failure.  The heart lacks regenerative capabilities.  As a consequence, injuries to the heart such as myocardial infarction (heart attack) place a massive burden on the ability of the heart to perform (contract and relax) properly. MyCardia™ has been shown to improve both the squeeze and relaxation of the heart which can improve how well the patient feels and increase their quality of life.

Explore more content of Falling Walls

Further Activities to have a look at